Previous 10 | Next 10 |
LEXINGTON, Mass. , July 7, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the first patient has been dosed in its Phase 1 trial evaluating CA-4948, a nove...
Source: Company website Companies like Curis ( CRIS ) attract speculators, traders and pumpers because of the relatively easy way the stock price can be temporarily manipulated to give it a big boost, or in some cases, respond to press releases issued to generate a quick boost in the s...
Gainers: Wah Fu Education (NASDAQ: WAFU ) +257% . More news on: Wah Fu Education Group Limited, Wins Finance Holdings Inc., Celldex Therapeutics, Inc., Stocks on the move, , Read more ...
Curis ( CRIS -18.2% ) inks agreement for the purchase and sale of 14M common shares at a purchase price of $1.25/share in a registered direct offering, for expected gross proceeds of $17.5M. More news on: Curis, Inc., Healthcare stocks news, , Stocks on the move, Read more ...
LEXINGTON, Mass. , June 11, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into definitive agreements with fundamental healthcare investors...
Gainers: Wins Finance (NASDAQ: WINS ) +252% . More news on: Wins Finance Holdings Inc., DPW Holdings, Inc., Curis, Inc., Stocks on the move, , Read more ...
3 High-Flying Penny Stocks To Watch In June 2020 There’s no question that penny stocks are some of the most volatile classes of stock out there. While it may look easy to trade penny stocks and make 10x your money, it takes a cool head and proven strategy to be consistent. The last ...
Thinly traded nano cap Curis (NASDAQ: CRIS ) is up 74% premarket on robust volume, poised to add to yesterday's 42% gallop. More news on: Curis, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
LEXINGTON, Mass. , June 10, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational ...
Curis, Inc. (CRIS) Q1 2020 Earnings Conference Call May 12, 2020 4:30 PM ET Company Participants Bill Steinkrauss - Chief Financial Officer Jim Dentzer - President & Chief Executive Officer Conference Call Participants Presentation Operator Good afternoon everyone...
News, Short Squeeze, Breakout and More Instantly...
2024-07-15 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Curis to Present at Upcoming Healthcare Conference in July PR Newswire LEXINGTON, Mass. , July 10, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IR...
2024-05-25 08:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...